Patient Journey Analysis for a Generic Drugs Manufacturer Helped Build Stronger Patient Relationships | Quantzig

Quantzig, a pure-play analytics solutions provider, has announced the
completion of their latest patient
journey analysis for a generic drugs manufacturer. A generic drugs
manufacturer wanted to find and develop an impartial view of their
patient segments to build stronger relationships by better understanding
them on an emotional level. They also wanted to tailor engagement
strategies to their experiential disease journey.

This press release features multimedia. View the full release here:

Patient Journey Analysis for a generic drugs manufacturer helped build stronger patient relationships. (Graphic: Business Wire)

According to the generic drugs experts at Quantzig,
“One of the biggest catalyst of the generic drugs industry is the
lower price of drugs when compared to the other branded drugs.”

The global generic drugs manufacturing encompasses companies that are
primarily engaged in the development, manufacture, and marketing of
generic drugs. Generic drugs are chemically indistinguishable from their
patented counterparts and are usually sold at large discounts.
Consequently, third-party payers and governments across the globe have
been able to save billions of dollars in healthcare expenditures and
resulted in lower copayments for patients. Also, factors like the patent
expiration of successful innovator drugs, an aging population, and a
quickly rising rate of chronic diseases are driving the growth of
generic drugs.

a proposal to see how Quantzig’s solutions can help you.

This patient journey analysis solution helped the client to measure and
understand the emotional journey and uncover key intervention points
along the digital patient journey. Furthermore, the client was also able
to gain a comprehensive overview of market segments.

To know more about the benefits of patient journey solution, request
a demo

This patient journey analysis provided benefits
that helped the client to:

This patient journey analysis offered
predictive insights on:

View the complete patient journey summary here:

About Quantzig

Quantzig is a global analytics and advisory firm with offices in the US,
UK, Canada, China, and India. For more than 15 years, we have assisted
our clients across the globe with end-to-end data modeling capabilities
to leverage analytics for prudent decision making. Today, our firm
consists of 120+ clients, including 45 Fortune 500 companies. For more
information on all of Quantzig’s services and the solutions they have
provided to Fortune 500 clients across all industries, please contact us.

View source version on

Leave a Comment

Your email address will not be published. Required fields are marked *